Balanced news tone
News Sentiment
069620 sentiment intelligence
Daewoong Pharmaceutical Co., Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-0.5% over one week, +9.8% over four weeks, trend inactive, and near fair-value range.
Number of shareholders of Daewoong Pharmaceutical Co., Ltd. – KRX:069620
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Number of shareholders of Daewoong Pharmaceutical Co., Ltd. – KRX:069620
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 19:13
- Source
- TradingView
IMM PE calls off talks to acquire CGBio from Daewoong Pharmaceutical’s owner
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- KED Global
Daewoong takes over Turn Bio’s longevity platform from Hanall
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- BioWorld News
Daewoong’s CLOPAM patch enables injection-free, weekly semaglutide
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Aug 2025 07:00
- Source
- BioWorld News
Daewoong partner Aeon lists on NYSE, seeks medical indications for embattled Jeuveau
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jul 2023 07:00
- Source
- BioWorld News
Daewoong accelerates investment in CDMO business
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jan 2023 08:00
- Source
- KED Global
ITC favors Medytox over Daewoong in botulinum toxin strain dispute
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2020 07:00
- Source
- Yonhap News Agency
Daewoong Pharmaceutical's Nabota wins FDA approval
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 07 Feb 2019 08:00
- Source
- Yonhap News Agency
Daewoong Pharm’s Botoxin Receives Marketing Approval in Canada
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 21 Aug 2018 07:00
- Source
- Businesskorea